Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Change-Receivables" stands at -0.2108 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 09/30/2023, the highest value since 12/31/2016.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.6541 Billion Hong Kong Dollars compared to the value the year prior.
The 1 year change is 0.6541 Billion Hong Kong Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change Receivables | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change Receivables | 486,508,953,600.00 |
![]() | AbbVie Inc - Change Receivables | 399,570,305,024.00 |
![]() | Roche Holding AG - Change Receivables | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change Receivables | 280,205,508,085.11 |